Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arno Fritsch

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Journal of Proteome Research|March 15, 2017
Symbiotic Interplay of Fungi, Algae, and Bacteria within the Lung Lichen Lobaria pulmonaria L. Hoffm. as Assessed by State-of-the-Art MetaproteomicsChristine Eymann, Christian Lassek, Uwe Wegner, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 25, 2019
Phase II Study of Roniciclib in Combination with Cisplatin/Etoposide or Carboplatin/Etoposide as First-Line Therapy in Patients with Extensive-Disease Small Cell Lung CancerMartin Reck, Leora Horn, Silvia Novello, et al.
The European Respiratory Journal|November 15, 2014
Riociguat for the treatment of chronic thromboembolic pulmonary hypertension: a long-term extension study (CHEST-2)Gérald Simonneau, Andrea M D'Armini, Hossein-Ardeschir Ghofrani, et al.
The New England Journal of Medicine|July 26, 2013
Riociguat for the treatment of chronic thromboembolic pulmonary hypertensionHossein-Ardeschir Ghofrani, Andrea M D'Armini, Friedrich Grimminger, et al.
Heart (British Cardiac Society)|December 25, 2016
Haemodynamic effects of riociguat in inoperable/recurrent chronic thromboembolic pulmonary hypertensionNick H Kim, Andrea M D'Armini, Friedrich Grimminger, et al.
The Lancet. Respiratory Medicine|April 13, 2016
Predictors of long-term outcomes in patients treated with riociguat for chronic thromboembolic pulmonary hypertension: data from the CHEST-2 open-label, randomised, long-term extension trialGérald Simonneau, Andrea M D'Armini, Hossein-Ardeschir Ghofrani, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Journal of Proteome Research|March 15, 2017
Symbiotic Interplay of Fungi, Algae, and Bacteria within the Lung Lichen Lobaria pulmonaria L. Hoffm. as Assessed by State-of-the-Art MetaproteomicsChristine Eymann, Christian Lassek, Uwe Wegner, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 25, 2019
Phase II Study of Roniciclib in Combination with Cisplatin/Etoposide or Carboplatin/Etoposide as First-Line Therapy in Patients with Extensive-Disease Small Cell Lung CancerMartin Reck, Leora Horn, Silvia Novello, et al.
The European Respiratory Journal|November 15, 2014
Riociguat for the treatment of chronic thromboembolic pulmonary hypertension: a long-term extension study (CHEST-2)Gérald Simonneau, Andrea M D'Armini, Hossein-Ardeschir Ghofrani, et al.
The New England Journal of Medicine|July 26, 2013
Riociguat for the treatment of chronic thromboembolic pulmonary hypertensionHossein-Ardeschir Ghofrani, Andrea M D'Armini, Friedrich Grimminger, et al.
Heart (British Cardiac Society)|December 25, 2016
Haemodynamic effects of riociguat in inoperable/recurrent chronic thromboembolic pulmonary hypertensionNick H Kim, Andrea M D'Armini, Friedrich Grimminger, et al.
The Lancet. Respiratory Medicine|April 13, 2016
Predictors of long-term outcomes in patients treated with riociguat for chronic thromboembolic pulmonary hypertension: data from the CHEST-2 open-label, randomised, long-term extension trialGérald Simonneau, Andrea M D'Armini, Hossein-Ardeschir Ghofrani, et al.
Pageof 2